Logothetis CJ - Search Results

1

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.

Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ. Strom SS, et al. Among authors: logothetis cj. Prostate. 2004 Sep 1;60(4):343-51. doi: 10.1002/pros.20060. Prostate. 2004. PMID: 15264247

2

Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy.

Wishnow KI, Levinson AK, Johnson DE, Tenney DM, Grignon DJ, Ro JY, Ayala AJ, Logothetis CJ, Swanson DA, Babaian RJ, et al. Wishnow KI, et al. Among authors: logothetis cj. Urology. 1992 Jan;39(1):12-6. doi: 10.1016/0090-4295(92)90033-s. Urology. 1992. PMID: 1728789

3

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

Logothetis CJ, Johnson DE, Chong C, Dexeus FH, Sella A, Ogden S, Smith T, Swanson DA, Babaian RJ, Wishnow KI, et al. Logothetis CJ, et al. J Clin Oncol. 1988 Oct;6(10):1590-6. doi: 10.1200/JCO.1988.6.10.1590. J Clin Oncol. 1988. PMID: 3171626

4

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. Among authors: logothetis cj. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

5

Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.

Herrada J, Dieringer P, Logothetis CJ. Herrada J, et al. Among authors: logothetis cj. J Urol. 1996 Feb;155(2):620-3. J Urol. 1996. PMID: 8558675 Clinical Trial.

6

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: logothetis cj. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

7

Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.

Ozen M, Navone NM, Multani AS, Troncoso P, Logothetis CJ, Chung LW, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: logothetis cj. Cancer Genet Cytogenet. 1998 Oct 15;106(2):105-9. doi: 10.1016/s0165-4608(98)00051-x. Cancer Genet Cytogenet. 1998. PMID: 9797773

8

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

9

Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancer.

Ozen M, Hopwood VL, Johnston DA, Babaian RJ, Logothetis CJ, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: logothetis cj. Urology. 1999 Feb;53(2):381-5. doi: 10.1016/s0090-4295(98)00487-7. Urology. 1999. PMID: 9933059

10

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.

Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. J Urol. 1999 Jan;161(1):304-8. J Urol. 1999. PMID: 10037428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters